Asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -17 years of age and older at the index date -Patients who had claim within 12 months prior to Index date -Patients who had a record of asthma diagnosis 12 and more months prior to Index date -Patients who had 4 or more "claims with for an asthma and record of ICS or ICS/LABA prescription for that visit" within 12 months prior to Index date
Exclusion criteria
Exclusion criteria: -Patients who didin't have the "claims with for an asthma and record of ICS or ICS/LABA prescription for that visit" within 6 months prior to Index date -Patients who didin't have the "claims with for an asthma and record of ICS or ICS/LABA prescription for that visit" during the period of more than 6 months and within 12 months prior to Index date
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Following patient proportion in treated asthma patients; severe asthma, uncontrolled severe asthma | — |
Countries
Japan
Contacts
Astrazeneca K.K Medical department Evidence & Observational Research